-
Patient PerspectivesLed by Steven Taylor, the Sjögren’s Syndrome Foundation is raising awareness of a little-known autoimmune disease
Patient Perspectives -
DiscoverySystematically exposing vulnerabilities of cancer cells
Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.
Discovery -
Access to HealthcareWomen in Science: Fionnuala Doyle
Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.
Access to Healthcare -
DiscoveryA researcher seeks the roots of plants’ healing power
Deep in a forest in the West African country of Ghana, two men are searching for plants that they hope could ultimately provide a cure for some of the world’s deadliest diseases.
Discovery -
Patient PerspectivesA patient’s perspective on biomarker testing
A lung cancer patient describes her path to diagnosis and what came next.
Patient Perspectives -
Patient PerspectivesFrom nurse to patient: facing an aggressive blood cancer
After being diagnosed with an aggressive form of leukemia, Ilana Massi defied the odds with the help of her friends and family.
Patient Perspectives -
Access to HealthcareHelping Syrian refugees manage chronic diseases
Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.
Access to Healthcare -
DiscoveryWomen in Science: Shilpa Shah-Mehta
Discovery -
DiscoveryInnovating on a trusted class of antibiotics to attack superbugs
A new compound aims to attack dangerous antibiotic-resistant bacteria.
Discovery -
DiscoveryWomen in Science: Cathryn Clary
Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.
Discovery -
From Our LabsMinion challenges assumptions about the genome
A diminutive protein prompts a closer look at DNA dark matter.
From Our Labs -
DiscoveryGoing global to meet local needs in China
Marc Pelletier traveled from Cambridge, MA to Shanghai, China, to launch new lines of research for the treatment of cancers that are common in China.
Discovery